Harima Chemicals Group (TSE:4410) Stock Price Eyes Value After Q2 Earnings

Harima Chemicals Group closed Friday at ¥1,355 after a strong run over the past three months, yet the real story sat in the Q2 2027 earnings just released. Net income excluding extra items came in at ¥1,718m on revenue of ¥31,725m, lifting basic earnings per share to ¥70.55. That profit step up now feeds into trailing earnings of ¥4,225m and a P/E of 7.8x, a level well below both peers and the broader Japanese chemicals sector. Short term traders watched the price. Long term holders are looking at valuation and considering the size of that gap.

Like the value on Harima Chemicals Group but want a tighter focus on balance sheet strength too? Scan our list of solid balance sheet and fundamentals stocks (21 results) for companies priced on similar earnings multiples with more robust financial profiles.

Q2 2027 Earnings Summary

• Revenue (Q2 2027 vs Q2 2026): ¥31,725m vs. ¥25,532m (up about 24%)
• Net Income (Excl. Extra Items, Q2 2027 vs Q2 2026): ¥1,718m vs. ¥441m (up very strongly, almost 4x)
• Basic EPS (Q2 2027 vs Q2 2026): ¥70.55 vs. ¥18.15 (up very strongly, close to 4x)
• Trailing Net Profit Margin (Last 12 Months vs Prior 12 Months): 3.7% vs. 1.0% (profitability improved on a trailing basis)

Ask Charlie what makes Harima Chemicals Group look so undervalued.

Harima Chemicals Group: earnings momentum backs the upside

For anyone leaning optimistic on Harima Chemicals Group, the latest quarter gives that view some real footing. Revenue of ¥31,725m and net income of ¥1,718m both run well ahead of the prior year period, and basic EPS has moved in the same direction. Trailing profit margins have also shifted higher to 3.7% from 1.0%. That mix of stronger sales, fatter profitability and a three month share price gain of about 26% suggests the diversified chemicals and electronic materials story is currently translating into healthier financial outcomes.

Short term strength, but cyclical risks not erased

Bears worry about cyclical end markets and pressure on industrial chemicals suppliers. The latest figures do not remove those issues, although they soften the near term sting. Profitability has improved on a trailing basis and quarterly earnings are far stronger than a year ago, so immediate stress on the business model looks lower than a cautious narrative implies. With the stock already up roughly 21% over 30 days and 26% over 90 days, the key risk for Harima Chemicals Group now is whether these stronger conditions can be sustained through future cycles.

After a sharp share price move, high debt and an uneven dividend record, it helps to ask whether these are isolated issues or early clues of deeper fragility. Review the independent risk analysis for Harima Chemicals Group which shows 3 important warning signs

Hunt For Quiet Earnings Gaps

Harima Chemicals Group just showed how a stronger quarter can reset expectations without fully closing the valuation gap. The real opportunity is spotting stocks that could be undervalued before stronger fundamentals draw wider attention.

• Company 1 - 36% below our estimate - helps rework aging logistics hubs and transit links as owners upgrade warehouses, ports and railway stations for heavier traffic.
• Company 2 - 44% below our estimate - ties its engineers to long stretch digital projects as corporations outsource verification, DX support and cloud system build outs.
• Company 3 - 37% below our estimate - installs tightly controlled air and cooling systems as factories, hospitals and data centers retrofit for stricter reliability demands.

Three companies from the same screener. Open every one of the 16 undervalued companies on it →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com